Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,586 | 19,744 | 31,533 | 24,310 | 32,823 |
| Marketable Securities | 56,332 | 61,598 | 53,535 | 69,712 | 72,795 |
| Receivables | 727 | 1,170 | 2,307 | 3,162 | 3,175 |
| TOTAL | $75,103 | $84,365 | $88,851 | $99,079 | $110,969 |
| Non-Current Assets | |||||
| PPE Net | 4,488 | 5,086 | 5,462 | 6,111 | 6,699 |
| Intangibles | 48,690 | 48,690 | 48,690 | 48,690 | 48,690 |
| Other Non-Current Assets | 3,560 | 4,103 | 4,574 | 1,929 | 1,929 |
| TOTAL | $56,738 | $57,879 | $58,726 | $56,730 | $57,318 |
| Total Assets | $131,841 | $142,244 | $147,577 | $155,809 | $168,287 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,550 | N/A | N/A | N/A | 4,926 |
| Accounts payable and accrued liabilities | 666 | 1,016 | 1,105 | 1,069 | 2,311 |
| Accrued Expenses | 6,419 | 5,410 | 5,474 | 7,007 | 9,614 |
| Other current liabilities | N/A | 2,545 | 2,777 | 4,526 | N/A |
| TOTAL | $11,888 | $11,509 | $11,989 | $12,602 | $16,851 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 18,573 | 21,109 | 22,895 | 19,147 | 23,302 |
| TOTAL | $18,573 | $21,109 | $22,895 | $19,147 | $23,302 |
| Total Liabilities | $30,461 | $32,618 | $34,884 | $31,749 | $40,153 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,130 | 15,019 | 13,769 | 12,440 | 11,503 |
| Common Shares | 16 | 15 | 13 | 12 | 169 |
| Retained earnings | -1,002,869 | -991,456 | -979,677 | -962,438 | -953,036 |
| Other shareholders' equity | 2,635 | 2,638 | 2,602 | 2,583 | 2,582 |
| TOTAL | $101,380 | $109,626 | $112,693 | $124,060 | $128,134 |
| Total Liabilities And Equity | $131,841 | $142,244 | $147,577 | $155,809 | $168,287 |